Header

UZH-Logo

Maintenance Infos

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study


Weigert, G; Michels, S; Sacu, S; Varga, A; Prager, F; Geitzenauer, W; Schmidt-Erfurth, U (2008). Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. British Journal of Ophthalmology, 92(3):356-360.

Statistics

Citations

Dimensions.ai Metrics
72 citations in Web of Science®
80 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

138 downloads since deposited on 21 Nov 2008
7 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Ophthalmology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Ophthalmology
Life Sciences > Sensory Systems
Life Sciences > Cellular and Molecular Neuroscience
Language:English
Date:March 2008
Deposited On:21 Nov 2008 13:21
Last Modified:01 Oct 2023 01:43
Publisher:BMJ Publishing Group
ISSN:0007-1161
OA Status:Hybrid
Publisher DOI:https://doi.org/10.1136/bjo.2007.125823
PubMed ID:18303156
  • Description: Verlags-PDF